Marica Rosaria Ippolito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marica Rosaria Ippolito has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Stefano Santaguida
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy
16 shared publications - Sara Martin
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy
15 shared publications - Uri Ben-David
Department of Human Genetics & Computational Medicine, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel
15 shared publications - Eldad David Shulman
Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
14 shared publications - Eytan Ruppin
Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
14 shared publications - Francesco Nicassio
Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy
14 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between the highly-aneuploid clones (SS51, SS111) and the pseudo-diploid clone (SS48).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between the highly-aneuploid clones (SS51, SS111) and the pseudo-diploid clone (SS48).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Details of cell lines, reagents and oligonucleotides used in the study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Details of cell lines, reagents and oligonucleotides used in the study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-8 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Supplementary Figure 1: Dosage compensation in trisomic cells occurs at both mRNA and protein levels (related to Fig. 1). Supplementary Figure 2: RNA degradation does not confound the results of the differential gene expression analyses (related to Fig. 2). Supplementary Figure 3: Aneuploid clones activate the nonsense-mediated decay (NMD) pathway, and depend on it for downregulating their gene expression (related to Fig. 3). Supplementary Figure 4: Increased dependency on the nonsense-mediated decay pathway is a general feature of aneuploid cells (related to Fig. 3). Supplementary Figure 5: Trisomic clones activate the miRNA-mediated RNA degradation pathway, and depend on it for downregulating their gene expression (related to Fig. 4). Supplementary Figure 6: Aneuploid cells depend on miRNA machinery cofactors PRKRA and TARBP2 (related to Fig. 4). Supplementary Figure 7: Multiple models of aneuploid cells experience proteotoxic stress and attenuate protein translation (related to Fig. 5). Supplementary Figure 8: Multiple models of aneuploid cells activate the proteasome, and depend on its activity for downregulating their protein expression (related to Fig. 6).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- Open Access
- 3 July 2025
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (8)
Sphingolipid synthesis maintains nuclear membrane integrity and genome stability during cell division
Lipid synthesis must be precisely regulated to support membrane growth and organelle biogenesis during cell division, yet little is known about how this process is coordinated with other cell cycle events. Here, we show that de novo synthesis of sphingolipids during the S and G2 phases of the cell cycle is essential to increasing nuclear membranes. Indeed, the products of serine palmitoyltransferase (SPT), long-chain bases, localize to the nucleus and are integral components of nuclear membranes in yeast and human cells. Importantly, inhibition of SPT fails to induce cell cycle arrest, causing nuclear membrane collapse and loss of viability in yeast cells. In human cells, this causes abnormal nuclear morphology and genomic instability, evidenced by the increased incidence of nuclear blebs, micronuclei, anaphase bridges, and multipolar mitosis. These results indicate that dysregulated cell division under low sphingolipid availability can drive several disease-associated phenotypes, including aberrant nuclear morphologies and genomic instability.
- 3 July 2025
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (8)
Open AccessSphingolipid synthesis maintains nuclear membrane integrity and genome stability during cell division
Lipid synthesis must be precisely regulated to support membrane growth and organelle biogenesis during cell division, yet little is known about how this process is coordinated with other cell cycle events. Here, we show that de novo synthesis of sphingolipids during the S and G2 phases of the cell cycle is essential to increasing nuclear membranes. Indeed, the products of serine palmitoyltransferase (SPT), long-chain bases, localize to the nucleus and are integral components of nuclear membranes in yeast and human cells. Importantly, inhibition of SPT fails to induce cell cycle arrest, causing nuclear membrane collapse and loss of viability in yeast cells. In human cells, this causes abnormal nuclear morphology and genomic instability, evidenced by the increased incidence of nuclear blebs, micronuclei, anaphase bridges, and multipolar mitosis. These results indicate that dysregulated cell division under low sphingolipid availability can drive several disease-associated phenotypes, including aberrant nuclear morphologies and genomic instability.
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Pre-ranked gene set enrichment analysis of differential mRNA expression between all aneuploid clones (SS6, SS119, SS51, SS111) and the pseudo-diploid clone (SS48)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
Gene set enrichment analysis of differential protein expression between the highly-aneuploid clones (SS51, SS111) and pseudo-diploid clones (SS48, SS31)
- Open Access
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine
- 2 December 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid Cells
PRISM screen results of human cancer cell lines treated with bortezomib, in the absence or presence of reversine